Arrowhead Pharmaceuticals (ARWR) Depreciation and Depletion (2017 - 2019)

Arrowhead Pharmaceuticals' Depreciation and Depletion history runs 3 years deep, the most recent figure standing at $2.1 million for Q2 2019.

• Quarterly Depreciation and Depletion rose 177.11% year-over-year to $2.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $5.1 million (changed N/A YoY) and the FY2018 annual result came in at $3.0 million, changed 0.3% from the prior year.
• Depreciation and Depletion was $2.1 million for Q2 2019 at Arrowhead Pharmaceuticals, up from $1.5 million in the prior quarter.
• Across five years, Depreciation and Depletion topped out at $2.1 million in Q2 2019 and bottomed at $716066.0 in Q4 2017.
• A 3-year average of $1.1 million and a median of $751689.5 in 2018 frame the typical range for Depreciation and Depletion.
• Annual changes were most pronounced in 2018 — Depreciation and Depletion increased 5.05% — and 2019, when it soared 177.11%.
• Arrowhead Pharmaceuticals' Depreciation and Depletion stood at $716066.0 in 2017, then rose by 5.05% to $752245.0 in 2018, then soared by 176.7% to $2.1 million in 2019.
• Business Quant data shows ARWR's Depreciation and Depletion at $2.1 million in Q2 2019, $1.5 million in Q1 2019, and $752245.0 in Q4 2018.